HMGB1 may be linked to immunosuppression in patients who survive septic shock

June 1, 2017, Federation of American Societies for Experimental Biology

A new study published online in the Journal of Leukocyte Biology suggests a new approach to treating patients with sepsis, one of the most frequent causes of morbidity and mortality in intensive care units (ICUs). Specifically, the report reveals that in the late stage of sepsis, HMGB1, or the "high mobility group box 1" protein, might be a target for future therapies because the protein plays a key role in the development of post-sepsis immunosuppression and sepsis-induced dysfunction of neutrophils (white blood cells).

"Therapeutic interventions for sepsis are limited to the use of antibiotics and fluid resuscitation, since specific pharmacological treatment is not available to prevent or correct sepsis-induced immunosuppression," said Jean-Marc Tadié, M.D., Ph.D., a researcher involved in the work from the Department of Infectious Diseases and Medical Intensive Care Unit at the Pontchaillou University Hospital, Rennes, France. "Targeting molecules such as HMGB1 represents a new therapeutic approach that could help people recover from septic shock."

To make their discovery, Tadié and colleagues first used a murine model of polymicrobial septic peritonitis with fluid resuscitation and antibiotic administration, mirroring standard care for humans. Using this model, they studied the late consequences of infection on neutrophils and the implication of HMGB1. In a second set of experiments, ex-vivo experiments were carried out to study the role of HMGB1 in neutrophil dysfunction in patients admitted to the ICU for septic shock. The researchers found that after sepsis, the ability of neutrophils to kill bacteria was diminished. They also found that HMGB1 was significantly increased in the late phase of sepsis. To establish the importance of HMGB1 in regulating sepsis-mediated neutrophil dysfunction, they demonstrated that neutralizing HMGB1 restored the neutrophils' ability to kill bacteria after .

"There is increasing evidence of immune paralysis or dysfunction in sepsis particularly in the 'adaptive' immune system," said John Wherry, Ph.D., Deputy Editor of the Journal of Leukocyte Biology. "The identification of a pathway that can rejuvenate neutrophil function is a major step forward because these cells of the 'innate' immune system can act much faster, a critical issue in "

Explore further: Scientists discover new method to restore function of white blood cells in septic patients

More information: Murielle Grégoire et al, Frontline Science: HMGB1 induces neutrophil dysfunction in experimental sepsis and in patients who survive septic shock, Journal of Leukocyte Biology (2017). DOI: 10.1189/jlb.5HI0316-128RR

Related Stories

Scientists discover new method to restore function of white blood cells in septic patients

December 1, 2016
New research findings published in the Journal of Leukocyte Biology, suggest that treating the white blood cells of sepsis patients with antibodies that block programmed cell death-1 (PD-1) and programmed cell death ligand ...

Scavenging of inflammatory molecules improves sepsis in mice

May 19, 2016
Sepsis is a life-threatening complication of infection in which the molecules that the body releases to fight an infection trigger widespread inflammatory responses, resulting in damage to multiple organ systems.

Machine learning may help in early identification of severe sepsis

May 24, 2017
A machine-learning algorithm has the capability to identify hospitalized patients at risk for severe sepsis and septic shock using data from electronic health records (EHRs), according to a study presented at the 2017 American ...

Scientists illuminate role of staph toxins in bacterial sepsis

February 2, 2017
Staphylococcus epidermidis bacteria are a significant health concern for hospitalized infants, children and anyone with implanted medical devices. The bacteria—typically skin dwellers—can infect the bloodstream and cause ...

Large number of patients admitted through ED with sepsis not given a formal diagnosis code

April 11, 2016
A large number of patients admitted through the emergency department with severe sepsis or septic shock are not given a specific International Classification of Disease (ICD) code used around the world to collect data on ...

Keeping cells in shape to fight sepsis

August 8, 2016
Boosting levels of a protein that controls the shape and activity of a crucial group of white blood cells improves survival and recovery chances during sepsis.

Recommended for you

Researchers discover influenza virus doesn't replicate equally in all cells

September 19, 2018
The seasonal flu is caused by different subtypes of Influenza A virus and typically leads to the death of half a million people each year. In order to better understand this virus and how it spreads, University of Minnesota ...

Flu season forecasts could be more accurate with access to health care companies' data

September 19, 2018
In an era when for-profit companies collect a wealth of data about us, new research from The University of Texas at Austin shows that data collected by health care companies could—if made available to researchers and public ...

Drugs that stop mosquitoes catching malaria could help eradicate the disease

September 18, 2018
Researchers have identified compounds that could prevent malaria parasites from being able to infect mosquitoes, halting the spread of disease.

Vaccine opt-outs dropped slightly when California added more hurdles

September 18, 2018
In response to spiking rates of parents opting their children out of vaccinations that are required to enroll in school—and just before a huge outbreak of measles at Disneyland in 2014—California passed AB-2109. The law ...

New evidence of a preventative therapy for gout

September 17, 2018
Among patients with cardiovascular disease, it's a common complaint: a sudden, piercing pain, stiffness or tenderness in a joint that lasts for days at a time with all signs pointing to a gout attack. Gout and cardiovascular ...

"Atypical" virus discovered to be driver of certain kidney diseases

September 14, 2018
An international research team led by Wolfgang Weninger has discovered a previously unknown virus that acts as a "driver" for certain kidney diseases (interstitial nephropathy). This "atypical" virus, which the scientists ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.